HanAll BioPharma Co., Ltd.
16 clinical trials · Sponsor
◉ Watch HanAll BioPharma Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty (NCT06926933) | HanAll BioPharma Co., Ltd. | 2024-12-12 |
| A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease (NCT06400589) | HanAll BioPharma Co., Ltd. | 2024-05-01 |
| A Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants (NCT06088784) | HanAll BioPharma Co., Ltd. | 2023-09-19 |
| A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye (NCT05109702) | HanAll BioPharma Co., Ltd. | 2021-11-18 |
| A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes (NCT03846453) | HanAll BioPharma Co., Ltd. | 2019-03-10 |
| A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes (NCT03334539) | HanAll BioPharma Co., Ltd. | 2017-11-05 |
Track HanAll BioPharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.